1. THE USE OF IMAGING IN PROSTATE CANCER STAGING - A UTILIZATION REVIEW
Fircanis Rizk, S, Horn Prsic, E, Freeman N
Providence VA Medical Center, Warren Alpert School of Medicine, Brown University, Providence, RI
2. THE USE OF A TELEHEALTH CLINIC TO SUPPORT PATIENTS RECEIVING RADIATION THERAPY AT A SITE DISTANT FROM THEIR PCPS
Fosmire H, Shapiro R
Roudebush VA Radiation Oncology, Indianapolis, IN
3. GAUGING THE USE OF SINGLE FRACTION RADIOTHERAPY FOR PAINFUL BONE METASTASES. THE EXPERIENCE OF A SINGLE VETERANS ADMINISTRATION RADIATION ONCOLOGY CENTER
Dawson GA, Glushko I, Cheuk AV
James J Peters VA Medical Center, Bronx NY
4. IMPROVING THE PERFORMANCE OF THE CHEMOTHERAPY CLINIC AT THE NFSG VA
Graney T
Palo Alto VA, Healthcare System, Palo Alto, CA
5. SPLIT COURSE PALLIATIVE RADIOTHERAPY FOR ADVANCED LUNG CANCER USING MODERN CT BASED PLANNING
Davis S, Fuster E, Makani Sr, Bazhenova L, Sandhu A
Department of Radiation Medicine and Applied Sciences, Divisions of Hematology and Oncology, and Pulmonary Medicine, University of California San Diego Moores Cancer Center, San Diego, CA
6. LOW DOSE SCREENING CT FOR HIGH RISK NSCLC/SCLC: THE PROVIDENCE VA’S EXPERIENCE
Cameron JC, Freeman NJ, Carroll D, Shindell M
Providence VA Medical Center
7. IMPROVING ACCESS OF PERSONALIZED CARE: PILOTING A TELE GENETIC PROGRAM
Schwartz JM, Schneider SL, DeHerrera M, Chavez RL, Razner SL, Wehner SD
New Mexico VAHCS, Albuquerque, New Mexico
8. INITIAL CYTOGENETIC FEATURES OF VETERAN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A NATIONAL VA TUMOR REGISTRY STUDY
Tomaska JM, Tarchand G, Oberle N, Mescher C, Morrison V
Minneapolis VA Health Care System, Minneapolis, MN
9. PATTERNS OF INITIAL TREATMENT IN VETERAN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A NATIONAL VA TUMOR REGISTRY STUDY
Tarchand G, Tomaska J, Oberle N, Mescher C, Morrison VA
Minneapolis VA Medical Center, Minneapolis, MN
10. TACKLING THE BURDEN OF OPIOID MEDICATION ASSOCIATED CONSTIPATION USING QOPI SCORES AND PDSA CYCLES
Kaur V, Sasapu A, Haider S, Issam M, Arnaoutakis K, Mehta P
University of Arkansas for Medical Sciences/Central Arkansas Veterans Health Care System, Little Rock, AR
11. HYPERCALCEMIA IN DIFFUSE LARGE B-CELL LYMPHOMA
Rodriguez N, Ng P, Prsic E, Fortunato D, Freeman N
Brown University, Providence, RI
12. BACILLUS CALMETTE-GUERIN SHORTAGE: NOW WHAT?
Schwartz JM, Schneider SL, Chavez RL, Wehner SD, DeHerrera M, Razner S
New Mexico VA Health Care System, Albuquerque, NM
13. DEVELOPMENT OF DISEASE SITE SPECIFIC SMART TEMPLATES IN RADIATION ONCOLOGY TO ENABLE PRACTICE ASSESSMENT ACROSS THE VETERANS HEALTHCARE ADMINISTRATION
Saraiya SA, Kapoor R, Moghanaki D, Chang M, Palta J, Hagan M
Virginia Commonwealth University, Richmond, VA
14. TELEHEMATOLOGY : IMPROVING ACCESS FOR VETERANS WITH SELECT HEAMATOLGIC DISORDERS
Szczapinski R, Booth C, Hendler F
Robley Rex VA Medical Center, Louisville, Kentucky
15. TRAVEL BURDEN AND DISTRESS IN VETERANS WITH HEAD AND NECK CANCER
Keating TM
VA Puget Sound Health Care System, Seattle, WA
16. NATIONAL VA DATA ON SORAFENIB THERAPY ADHERENCE FOR VETERANS WITH HEPATOCELLULAR CARCINOMA
Malhotra S, Wu DPH, Park YHA
North Central Bronx Hospital, Bronx, NY; Columbia University Department of Hematology and Oncology, NY, NY
17. ASSESSMENT OF BODY WEIGHT AFTER COMPLETION OF RADIOTHERAPY WITH OR WITHOUT CHEMOTHERAPY AND WITH OR WITHOUT PROPHYLACTIC FEEDING TUBE PLACEMENT IN HEAD AND NECK CANCER
Reddy E,Moutafis E,Higby E, Huang C, Latif S, Park J
Kansas City VA Medical Center-Dept. of Radiation Oncology, Kansas City, MO
18. SIMULTANEOUS INTEGRATED BOOST(SIB) IN LIEU OF VAGINAL BRACHYTHERAPY(VBT) BOOST IN ENDOMETRIAL CANCER
Reddy E, Sexton L, Kurup R
Kansas City VA Medical Center-Dept. of Radiation Oncology, Kansas City, MO
19. BRENTUXIMAB VEDOTIN IN A PATIENT WITH AGGRESSIVE SYSTEMIC MASTOCYTOSIS AND PURE RED CELL APLASIA
Cooper KA, Richter J, Reder N, Henry E, Phelan K, Czerlanis C, Bhoopalam N
Edward Hines Jr. VA Hospital, Hines, IL; James A. Lovell Federal Health Care Center, North Chicago, IL; University of Washington School of Medicine, Seattle, WA; Loyola University Stritch School of Medicine, Loyola University Medical Center, Maywood, IL
20. CANCER CACHEXIA AND SURVIVAL IN PATIENTS WITH LUNG CANCER BY HISTOLOGY: WHO IS MOST AT RISK?
Simeunovic K
Ichan School of Medicine /James J Peterson VA Medical Center Internal Medicine Residency Program, New York, NY
21. FREQUENCY OF EGFR MUTATIONS AND ALK REARRANGEMENTS IN PULMONARY CARCINOMAS AT THE MPLS VAMC
Manivel JC, Aslan D
Minneapolis VAMC Minneapolis, MN
22. THE IMPORTANCE OF LYMPH NODE RETRIEVAL AND LYMPH NODE RATIO IN MALE PATIENTS WITH COLORECTAL CANCER-5 YEAR RETROSPECTIVE SINGLE INSTITUTION STUDY
Gavrancic T, Malhotra S, Jain V, Liu Q, Park YHA
Icahn School of medicine at Mount Sinai (Bronx) Program, James J Peters Veterans Affairs Medical Center, Bronx, NY
23. PATIENT EXPECTATIONS OF PALLIATIVE CANCER TREATMENT FOR NON-CURABLE MALIGNANCIES: A PILOT STUDY
Faricy-Anderson K, Allen S, Bishop K, Freeman N, Mor V
Alpert Medical School of Brown University, Providence, RI; Brown University School of Public Health, Providence, RI; Providence Veterans Affairs Medical Center, Providence, RI
24. BUILDING A CENTER FOR TRANSLATIONAL MOLECULAR IMAGING & THERAPY OF CANCER: THE TRUMAN VA EXPERIENCE
Rold TL, Berendzen AF, Bernskoetter NE, Hoffman TJ
Truman VA Hospital, Columbia, MO & University of Missouri-Columbia, MO
25. A VETERAN HEALTH ADMINISTRATION DISEASE MANAGEMENT PROGRAM:THE HUDSON VALLEY MODEL
Dawson GA, Ramirez D, Thomas S, Williams D, Gentile D, Kelly MD
James J Peters VA Med Center(Bronx NY), Hudson Valley VA Health Center(Wappinger Falls, NY) and New Jersey Veterans Affairs Health Care System (East Orange, NJ).
26. BOMBESIN RESEARCH: THE PROSTATE CANCER CONNECTION
Bernskoetter NE, Bernedzen AF, Rold TL, Hoffman TJ
Harry S. Truman VA Hospital, Columbia, MO & University of Missouri-Columbia, MO
27. PATTERNS OF FAILURE AND SURVIVAL ANALYSIS OF ADVANCED TONSILLAR CANCER TREATED WITH IMRT RADIATION THERAPY AND CHEMOTHERAPY AND IMPLICATIONS OF HPV-POSITIVE TUMORS IN MANAGEMENT
Albert AA, Giri SPG, Kanakamedala MR, Hamilton RH, Shenoy V
Sonny Montgmomery VA Medical Center and University of Mississippi Medical Center, Jackson, MS
28. IMPROVING ACCESS TO CARE FOR VETERANS REFERRED FOR STEM CELL TRANSPLANT USING VIDEO BASED TELEMEDICINE
Hassler M, Lucid C
Tennessee Valley Healthcare System Nashville, TN
29. MOLECULAR IMAGING OF ER STATUS IN BREAST CANCER: A PRECLINICAL STUDY
Szczodroski AF, Rold TL, Bernskoetter NE, Hoffman TJ, Berendzen A
Truman VA Hospital, Columbia, MO & University of Missouri-Columbia, MO
30. IMPACT OF TREATMENT SEQUENCING ON OUTCOMES AND COSTS IN RELAPSED LOW-GRADE OR FOLLICULAR B-CELL NON-HODGKIN’S LYMPHOMA
Carson KR, Cook DF, Weidner SM
St. Louis VA Healthcare System and Washington University, St. Louis, MO
31. AUDIOLOGIC REHABILITATIVE SERVICE UTILIZATION AMONG VETERANS EXPOSED TO CISPLATIN: A RETROSPECTIVE REVIEW
Dullard B, Reavis KM, Konrad-Martin D, McMillan GP, Dille M
VA Portland Healthcare System, Portland, OR
32. COLORECTAL CANCER STATISTICS AMONG PATIENTS REPORTED IN THE VETERANS AFFAIRS CENTRAL CANCER REGISTRY
Zullig LL, Smith VA, Danus S, Schnell M, Lindquist J, Provenzale D, Jackson GL, Weinberger M, Kelley MJ, Bosworth HB
Durham VA Medical Center, Durham, NC
33. A RETROSPECTIVE ANALYSIS OF THE ASSOCIATION OF DIOXIN (AGENT ORANGE) EXPOSURE AND CUTANEOUS T-CELL LYMPHOMA
Vinnakota R, Kumar R, Del Guzzo C
James J. Peters VAMC, Columbia University, Bronx, NY
34. VETERANS WITH CASTRATION-RESISTANT PROSTATE CANCER: CHARACTERISTICS AND TREATMENT
Silva A1, Henry E1, Bhoopalam N1, Gupta G1, Zullig LL2, Faricy-Anderson K3, Crawford R4, Klein MA5, Cosgriff S6, Dalia Mobarek7
1 Hines, Jr. VA Hospital, Hines, IL, 2 Center for Health Services Research in Primary Care, Durham VA Medical Center, Durham, NC, 3 Providence VA Medical Center, Providence, R, 4 Tucson VA Medical Center, Tucson, AZ, 5 Minneapolis VA Medical Center, MN
35. UTILIZATION OF FUSION PET/CT IN MAPPING SURGICAL/MEDICAL TREATMENT ALGORITHMS: INDIVIDUALIZING PATIENT CARE FOR SUSPICIOUS COLORECTAL MASSES
Valdez-Boyle LS, Schwartz JM
Raymond G. Murphy VAMC, Albuquerque, NM
36. BEST PRACTICES: UTILIZATION OF ONCOLOGY PHARMACISTS IN THE VA
Kaster LM, Crawford R, Diven MC, Houranieh JM
Boise VAMC, Boise, ID; SAVAHCS, Tuscon, AZ; Phoenix VAHCS, Phoenix, AZ, Lexington, KY VAMC
37. PREVALENCE OF PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING INFORMED CONSENT AMONG VETERAN MALES AGES 55-69
Prsic E, Rodriguez N, Rizk S
Brown University, Providence, RI
38. PROMOTING MINDFULNESS PRACTICE AMONG VETERANS WITH CANCER
Mesidor MM, Boling TB, Mehta P, Kunthur A
Central Arkansas Veterans Healthcare System, Little Rock, AR
39. IMPROVING PATIENT ACCESS TO CARE: A NURSE LED INITIATIVE
Milner B, Burleson R, Nester D
Louis Stokes Cleveland VA Medical Center, Cleveland, OH
40. RARE CASE OF IMMUNOHISTO-NEGATIVE CAT-SCRATCH DISEASE MASQUERADING AS RELAPSED HODGKIN’S LYMPHOMA
Tan-Shalaby JL, Habib-Bein N, Shah R, Carrick J
Pittsburgh VA Healthcare System, Pittsburgh, PA
41. MAKING DISTRESS SCREENING USEFUL FOR NURSING AND SOCIAL WORK
Jenkins KL, Willison JR
VAPORHCS, Portland, OR
42. PSA RESPONSE RATES FAR EXCEED EXPECTATIONS IN TREATING ASYMPTOMATIC, ANDROGEN RESISTANT PROSTATE CANCER (ARPC) WITH ABIRATERONE
Hendler FJ, Sherrard K, Szczapinski R
Robley Rex VA Medical Center, Louisville, KY
43. COMPARISON OF INITIAL DIAGNOSIS AND TREATMENT FOR HEPATOCELLULAR CARCINOMA (HCC) BETWEEN VETERANS AFFAIRS (VA) AND NON VETERAN POPULATIONS
Susanibar A, Sandra P, Siegel ER, Govindarajan R
Central Arkansas Veterans Healthcare System, Little Rock, AR
44. A RETROSPECTIVE EVALUATION OF OUTCOMES IN VETERAN PATIENTS WITH AGENT ORANGE EXPOSURE AND PROSTATE CANCER
Lim S, Crawford R
SAVAHCS, Tucson, AZ
45. INCIDENT CHRONIC KIDNEY DISEASE FOLLOWING KIDNEY CANCER SURGERY
Lamberts R, Thomas I, Chung B, Sonn G, Fan A, Srinivas S, Wagner T, Chertow G, Brooks J, Leppert JT
VA Palo Alto, Palo Alto, CA
46. THE EFFICACY OF ABIRATERONE PRE- AND POST- DOCETAXEL AND SEQUENTIAL USE OF ENZALUTAMIDE AFTER ABIRATERONE IN VETERAN PATIENTS WITH METASTATIC CASTRATE-RESISTANT PROSTATE CARCINOMA
Liman A, Shields J, Cockcroft M, Passero V, Tan J, Rai H, Blakowski S, Tokarsky J
VA Pittsburgh Healthcare System, Pittsburgh, PA
47. DISCREPANCY IN HISTOLOGIC SUBTYPES OF NON-SMALL CELL LUNG CANCER BETWEEN VETERANS AND THE GENERAL POPULATION
Assi HA, Ball E, Williams B, Mehdi S
Albany VA Medical Center, Albany, NY
48. AROMATHERAPY TO REDUCE ANXIETY IN RADIATION THERAPY
Kaltenbach KM, Semrad JA, Glime DL, Hagle ME
Clement J Zablocki VA Medical Center, Miwaukee WI
49. EPIDEMIOLOGY OF STAGE IV THYROID CANCER PATIENTS: A REVIEW OF THE NATIONAL CANCER DATABASE 2000-2012
Olson E1, Wolfe K1, Droessler J1, Gries J1, Silberstein P1,2
1 Creighton University School of Medicine, Omaha, NE; 2 VA Omaha Medical Center, Omaha, NE
50. IMPROVING THE ACCURACY OF ORDERING AND REPORTING FOR SEND-OUT LABORATORY STUDIES
Agnew E, Smith F, Lee J, Kuykendall A, Kaplan K, Goodman M, Streer N, Miller A, de Comarmond C, Pemmaraju S, Ruiz J
Salisbury VA Medical Center, Salisbury, NC
51. IMPLEMENTATION OF THE 21 GENE RISK SCORE ASSAY, ONCOTYPEDX BREAST, WITHIN THE VA
Lynch J, Berse B, Filipski K, Freedman A, DuVall S, Venne V, Kelley M
VA Salt Lake City Healthcare System, VINCI, Salt Lake City, UT
52. NATALIZUMAB-ASSOCIATED MELANOMA: A REPORT OF 139 CASES FROM THE SOUTHERN NETWORK ON ADVERSE REACTIONS (SONAR)
Noxon V, Bennett C
University of South Carolina, Columbia, SC
53. DID THE FDA BLACK BOX WARNING HAVE ANY EFFECT ON ERYTHROPOIESIS STIMULATING AGENT USE?
Noxon V, Bennett C
University of South Carolina, Columbia, SC
54. PATTERNS IN THE USE OF NEOADJUVANT AND ADJUVANT THERAPY IN STAGE II AND III RECTAL CANCER AND ASSOCIATED SURVIVAL
Wolfe K, Droessler J, Olson E, Gries J, Goyal G, Silberstein PT
Creighton University School of Medicine, Omaha, NE; VA Omaha Medical Center, Omaha, NE
55. STAGE IV RECTAL CANCER TRENDS BY YEAR- A REVIEW OF THE NATIONAL CANCER DATABASE 1998-2009
Droessler JD, Wolfe KM, Olson E, Silberstein PT
Creighton University School of Medicine, Omaha, NE
56. TESTING FOR BRCA1/BRCA2 IN THE VA
Venne V, Berse B, DuVall S, Chun D, Filipski K, Kelley M, Lynch J
VA Salt Lake City Healthcare System
57. PILOT STUDY: IS IN-NETWORK CARE FOR VETERANS DIAGNOSED WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM) FEASIBLE WITH VAHCS?
Siegert CJ1,2, Cohen DM1, 2, 3, Shoni M1,2, Huang Q4, Lally J1,5, Goldstein R9, Jati A6, Powsner R7, Jacobson D8, Huang K 12, Amirfarzan H10,11, Srinivasa V10,11, Itani K 5, Lebenthal A
1Division of General Thoracic Surgery, BVAHCS , WRVA Campus, 1400 VFW Parkway, West Roxbury, MA
2Division of General Thoracic Surgery, Brigham and Women’s Hospital, 75 Francis St., Boston MA
3International Mesothelioma Program, Brigham and Women’s Hospital, 75 Francis St., Boston MA,
4Department of Pathology, BVAHCS, WRVA Campus, 1400 VFW Parkway, West Roxbury, MA
5Department of Surgery, BVAHCS, WRVA Campus, 1400 VFW Parkway, West Roxbury, MA
6Department of Radiology, BVAHCS, WRVA Campus, 1400 VFW Parkway, West Roxbury, MA
7Department of Nuclear Medicine, BVAHCS, WRVA Campus, 1400 VFW Parkway, West Roxbury, MA
8Department of Medical Oncology , BVAHCS, JP Campus, 150 south Huntington av., Jamaica Plain, MA
9Department of Pulmonary Medicine, BVAHCS, WRVA Campus, 1400 VFW Parkway, West Roxbury, MA
10Surgical Critical Care, BVAHCS, WRVA Campus, 1400 VFW Parkway, West Roxbury, MA
11Department of Anesthesia, BVAHCS, WRVA Campus, 1400 VFW Parkway, West Roxbury, MA
12Department of Radiation Oncology, BVAHCS, JP Campus, 150 South Huntington Av, Jamaica Plain, MA
| Page
Share with your friends: |